DNL-919

N/A

Report date: 2025/03/18 15:32:05

Base Information

Drug NameDNL-919
Drug Alias NameDNL-919TAK-920ATV-TREM2ATV:TREM2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTriggering receptor expressed on myeloid cells 2 modulators
TargetsTriggering receptor expressed on myeloid cells 2
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDenali Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDenali Therapeutics IncTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A